
Zemasin Tablet 25
Marketer
Oncozest
Salt Composition
Exemestane (25mg)
Overview Zemasin Tablet 25
Estrofem 25mg tablets are an aromatase inhibitor indicated for postmenopausal women with breast cancer. This medication manages estrogen levels, thereby hindering cancer cell proliferation. Estrofem 25mg is also used adjunctively in early-stage breast cancer to reduce recurrence risk. Consistent daily dosing, ideally with food, maximizes therapeutic efficacy. Dosage and frequency are determined by your physician based on individual needs and treatment goals. Always follow your doctor's instructions. Swallow tablets whole with water. Continue treatment as prescribed. Common side effects include sleep disturbances, headaches, nausea, increased hunger, and arthralgia. Report any concerning or persistent side effects to your doctor; management strategies may be available. Prior to commencing treatment, inform your physician if you are premenopausal, have liver or kidney impairment, or are taking other medications (potential drug interactions may occur). Disclose any pregnancy or breastfeeding status. Your doctor may order blood tests to monitor vitamin D levels and bone density.
Uses of Zemasin Tablet 25
Malignant mammary tumor
Major Benefits of Zemasin Tablet 25:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Zemasin 25mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Zemasin Tablet 25:
- Insomnia (difficulty in sleeping)
- Headache
- Nausea
- Increased sweating
- Musculoskeletal (bone, muscle or joint) pain
- Fatigue
- Increased appetite
How to use Zemasin Tablet 25:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Zemasin 25mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Zemasin Tablet 25 works:
Zemasin 25 mg tablets function as an aromatase inhibitor, reducing the body's estrogen production. This reduction in estrogen levels can inhibit or halt the growth of certain breast cancer cells dependent on estrogen for proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Zemasin Tablet 25 may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
The use of Zemasin 25mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animals and pregnant humans indicates substantial risks to the fetus.
Breast feedingUNSAFE
Lactation and Zemasin 25mg tablets are incompatible. Evidence indicates potential infant toxicity associated with this medication.
DrivingUNSAFE
Taking Zemasin 25mg tablets may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyUNSAFE
The use of Zemasin 25 mg tablets is likely inadvisable for individuals with renal impairment and should be omitted. Medical advice is recommended.
LiverUNSAFE
Individuals with liver conditions should likely avoid Zemasin 25mg tablets due to potential safety concerns. A physician's consultation is recommended.
What if you forget to take Zemasin Tablet 25 :
Should you forget a Zemasin Tablet 25 dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication schedule. Avoid taking a double dose.
Facts to Know About Zemasin Tablet 25
| Label | Value |
|---|---|
| Chemical Type | Androgen Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
